scholarly article | Q13442814 |
P50 | author | Heikki Rauvala | Q38644081 |
P2093 | author name string | Imai S | |
Parkkinen J | |||
Rouhiainen A | |||
P433 | issue | 6 | |
P304 | page(s) | 1087-1094 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
P1476 | title | Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation | |
P478 | volume | 84 |
Q33358039 | A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes |
Q48732970 | ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury |
Q33676193 | Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET |
Q64092947 | Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome |
Q26744644 | Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases |
Q42355573 | Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice |
Q35953553 | HMGB1 is a therapeutic target for sterile inflammation and infection |
Q28577024 | High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues |
Q41952666 | High mobility group box 1 protein induction by Mycobacterium bovis BCG. |
Q28118997 | High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine |
Q37206315 | High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease |
Q21034098 | Human malarial disease: a consequence of inflammatory cytokine release |
Q35971929 | Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. |
Q90647008 | Inhibition of Homophilic Interactions and Ligand Binding of the Receptor for Advanced Glycation End Products by Heparin and Heparin-Related Carbohydrate Structures |
Q37457072 | Innate immunity, coagulation and placenta-related adverse pregnancy outcomes |
Q28078773 | Intercellular Interactions as Regulators of NETosis |
Q27023542 | Ménage à Trois in stress: DAMPs, redox and autophagy |
Q34334123 | New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal |
Q35838590 | Pathogenesis of malaria and clinically similar conditions |
Q47118391 | Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke |
Q88123532 | Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice |
Q38362628 | Platelet transfusion - the new immunology of an old therapy |
Q36335907 | Platelet-derived HMGB1 is a critical mediator of thrombosis. |
Q42155026 | Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes |
Q38542454 | Platelets and Their Interactions with Other Immune Cells |
Q48136773 | Platelets at the crossroads of thrombosis, inflammation and haemolysis. |
Q26741571 | Platelets: New Bricks in the Building of Neutrophil Extracellular Traps |
Q47220872 | Post-translational modifications of high mobility group box 1 and cancer |
Q35922965 | RETRACTED ARTICLE: HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms |
Q38682450 | Regulation of Posttranslational Modifications of HMGB1 During Immune Responses |
Q35610210 | Role of HMGB1 in cardiovascular diseases |
Q41836991 | Staphylococcal toxic shock syndrome toxin-1 induces the translocation and secretion of high mobility group-1 protein from both activated T cells and monocytes. |
Q41967145 | Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products |
Q91819199 | Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy |
Q35108949 | The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers |
Q38195181 | The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo |
Q33732343 | The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis |
Q27010599 | The translocation of nuclear molecules during inflammation and cell death |
Q38103542 | Transfusion-Related Acute Lung Injury: The Work of DAMPs. |
Q37421806 | Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. |
Q47153310 | Trypsinogen Activation Peptide Induces HMGB1 Release from Rat Pancreatic Acinar Cells |
Q26749091 | Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis |
Search more.